Gene · 23049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive coverage insurance for cells: revealing links between ribosome collisions, stress responses and mRNA surveillance. | RNA Biol | 2022 | 35491909 | PubTator, text mining | PubMed |
| Emerging role of circular RNAs in the pathogenesis of ovarian cancer. | Cancer Cell Int | 2022 | 35488239 | PubTator, text mining | PubMed |
| CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway. | Nat Commun | 2022 | 35487895 | PubTator, text mining | PubMed |
| Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma. | Int J Immunopathol Pharmacol | 2022 | 35467432 | PubTator, text mining | PubMed |
| The mid-secretory endometrial transcriptomic landscape in endometriosis: a meta-analysis. | Hum Reprod Open | 2022 | 35464885 | PubTator, text mining | PubMed |
| Periodic attention operates faster during more complex visual search. | Sci Rep | 2022 | 35461325 | PubTator, text mining | PubMed |
| Pulmonary vascular volume is associated with DLCO and fibrotic score in idiopathic pulmonary fibrosis: an observational study. | BMC Med Imaging | 2022 | 35461214 | PubTator, text mining | PubMed |
| Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma. | Biomed Pharmacother | 2022 | 35461090 | PubTator, text mining | PubMed |
| The Dysregulation of the Renin-Angiotensin System in COVID-19 Studied by Serum Proteomics: Angiotensinogen Increases with Disease Severity. | Molecules | 2022 | 35458690 | PubTator, text mining | PubMed |
| Construction of a ceRNA Network Related to Rheumatoid Arthritis. | Genes (Basel) | 2022 | 35456453 | PubTator, text mining | PubMed |
| UPF1 Inhibits Hepatocellular Carcinoma Growth through DUSP1/p53 Signal Pathway. | Biomedicines | 2022 | 35453543 | PubTator, text mining | PubMed |
| Retinal Circular RNA hsa_circ_0087207 Expression Promotes Apoptotic Cell Death in Induced Pluripotent Stem Cell-Derived Leber's Hereditary Optic Neuropathy-like Models. | Biomedicines | 2022 | 35453537 | PubTator, text mining | PubMed |
| Human UPF3A and UPF3B enable fault-tolerant activation of nonsense-mediated mRNA decay. | EMBO J | 2022 | 35451084 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma. | Oncologist | 2022 | 35438782 | PubTator, text mining | PubMed |
| Major Role for Cellular MicroRNAs, Long Noncoding RNAs (lncRNAs), and the Epstein-Barr Virus-Encoded BART lncRNA during Tumor Growth In Vivo. | mBio | 2022 | 35435703 | PubTator, text mining | PubMed |
| hnRNP A1 and hnRNP C associate with miR-17 and miR-18 in thyroid cancer cells. | FEBS Open Bio | 2022 | 35417090 | PubTator, text mining | PubMed |
| Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study. | Stroke | 2022 | 35414198 | PubTator, text mining | PubMed |
| Discriminating Potential Genetic Markers for Complete Response and Non-Complete Response Patients to Neoadjuvant Chemotherapy with Locally Advanced Rectal Cancer. | Int J Environ Res Public Health | 2022 | 35409691 | PubTator, text mining | PubMed |
| High-Value Chemicals from Electrocatalytic Depolymerization of Lignin: Challenges and Opportunities. | Int J Mol Sci | 2022 | 35409138 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23049/papers?page=32